Biomarker-based selection of therapy for colorectal cancer
JS Ross - Biomarkers in Medicine, 2011 - Taylor & Francis
Colorectal cancer (CRC) has been re-classified based on molecular analyses of various
genes and proteins capable of separating morphologic types of tumors into molecular …
genes and proteins capable of separating morphologic types of tumors into molecular …
Biomarker-based selection of therapy for colorectal cancer
JS Ross - Biomarkers in Medicine, 2011 - go.gale.com
In the USA, colorectal cancer (CRC) is the second leading cause of cancer mortality, with
160,000 new cases diagnosed each year and 57,000 CRC-related deaths [1]. The age …
160,000 new cases diagnosed each year and 57,000 CRC-related deaths [1]. The age …
Biomarker-based selection of therapy for colorectal cancer.
JS Ross - Biomarkers in Medicine, 2011 - europepmc.org
Colorectal cancer (CRC) has been re-classified based on molecular analyses of various
genes and proteins capable of separating morphologic types of tumors into molecular …
genes and proteins capable of separating morphologic types of tumors into molecular …
Biomarker-based selection of therapy for colorectal cancer
JS Ross - Biomarkers in medicine, 2011 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) has been re-classified based on molecular analyses of various
genes and proteins capable of separating morphologic types of tumors into molecular …
genes and proteins capable of separating morphologic types of tumors into molecular …
Biomarker-based selection of therapy for colorectal cancer
JS Ross - Biomarkers in Medicine, 2011 - search.proquest.com
Colorectal cancer (CRC) has been re-classified based on molecular analyses of various
genes and proteins capable of separating morphologic types of tumors into molecular …
genes and proteins capable of separating morphologic types of tumors into molecular …